• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.64% Nasdaq Down 0.55%

    Puma Biotechnology, Inc. (PBYI)

    -NYSE
    195.45 Down 4.60(2.30%) May 29, 4:02PM EDT
    |After Hours : 198.00 Up 2.55 (1.30%) May 29, 6:55PM EDT
    Add to Portfolio
    Prev Close:200.05
    Open:200.97
    Bid:170.00 x 100
    Ask:198.00 x 100
    1y Target Est:276.80
    Beta:-1.95
    Earnings Date:Aug 10 - Aug 14 (Est.)
    Day's Range:193.60 - 201.49
    52wk Range:53.63 - 279.37
    Volume:1,523,349
    Avg Vol (3m):443,246
    Market Cap:6.28B
    P/E (ttm):N/A
    EPS (ttm):-5.72
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Related Video

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):N/A
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-6.22
    Quarterly EPS Est (Jun-15) :-1.55
    Mean Recommendation*:1.9
    PEG Ratio (5 yr expected):0.85

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Puma Biotechnology, Inc., a development stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of products for the treatment of various forms of cancer. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback